Zoetis (ZTS) Common Equity (2012 - 2026)
Zoetis (ZTS) reported Common Equity of $3.15 billion for Q2 2026, down 39.0% from $5.16 billion a year earlier and down 2.6% from the prior quarter.
Powered by 
Analysis
Zoetis (ZTS) Common Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, Zoetis posted Common Equity of $3.42 billion, down 29.5% from FY2024.
- Common Equity has a five-year compound annual growth rate of -2.0% (FY2020 to FY2025).
- By year, Common Equity came in at $4.84 billion in FY2024 (-2.9%), $4.99 billion in FY2023 (+13.4%), $4.4 billion in FY2022 (-3.1%) and $4.54 billion in FY2021 (+20.4%).
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q2 2020.
- Year over year, Common Equity has now declined in each of the last three quarters, with an average decline of 12.3% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 29.8%); the low point was Q2 2026 (a decline of 39.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.23 billion (Q1 2026), $3.42 billion (Q4 2025) and $5.4 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Zoetis | 29.58 Bn | 21.43 Bn | 1.05 Bn | 3.15 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.15 Bn |
| Mar 31, 2026 | 3.23 Bn |
| Dec 31, 2025 | 3.42 Bn |
| Sep 30, 2025 | 5.40 Bn |
| Jun 30, 2025 | 5.16 Bn |
| Mar 31, 2025 | 4.87 Bn |
| Dec 31, 2024 | 4.84 Bn |
| Sep 30, 2024 | 5.23 Bn |
| Jun 30, 2024 | 4.96 Bn |
| Mar 31, 2024 | 5.05 Bn |
| Dec 31, 2023 | 4.99 Bn |
| Sep 30, 2023 | 5.07 Bn |
| Jun 30, 2023 | 4.62 Bn |
| Mar 31, 2023 | 4.49 Bn |
| Dec 31, 2022 | 4.40 Bn |
| Sep 30, 2022 | 4.66 Bn |
| Jun 30, 2022 | 4.58 Bn |
| Mar 31, 2022 | 4.66 Bn |
| Dec 31, 2021 | 4.54 Bn |
| Sep 30, 2021 | 4.68 Bn |
API Access
Zoetis Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ZTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ZTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ZTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();